Torrent Pharma Inc. is recalling 6,228 bottles of Carbamazepine (Tegretol), a prescription medication used to treat seizures and nerve pain. The recall was initiated because the tablets failed dissolution specifications, meaning they may not dissolve properly in the body. If the drug does not dissolve correctly, it may not be absorbed into the bloodstream at the intended rate, potentially leading to lower-than-expected levels of medication in the system. Consumers should consult their healthcare provider or pharmacist regarding their medication.
The failure to meet dissolution specifications can result in the medication not working as intended. For patients relying on Carbamazepine to prevent seizures or manage chronic pain, inconsistent absorption could lead to a loss of symptom control or an unexpected return of seizure activity.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.